Newsletter
Licensing Collaboration Deal
News filed under Licensing/Collaboration Deal , newest first.
Showing 1–5 of 10 stories
Latest story
Sanofi and Cheplapharm Plan Strategic Partnership for 20 Mature Medicines
Cheplapharm to Take Over Selected Medicines and Three Manufacturing Sites Sanofi and Cheplapharm...
Read story
Rznomics Joins Lilly Gateway Labs in San Diego to Advance RNA-Based Gene Therapies
Rznomics Inc., a South Korean clinical-stage biopharmaceutical company focused on RNA-based gene the...
Read story
Amplitude Therapeutics and Lilly Team Up to Develop New taRNA Vaccines for Infectious Diseases
New Collaboration Will Focus on Vaccine Candidates for Diseases With High Unmet Need Amplitude Th...
Read story
Almirall and CrystalO Partner to Discover New Treatments for Skin Diseases
Almirall, S.A., a global biopharmaceutical company focused on medical dermatology, has entered into...
Read story
Kaigene Licenses Autoimmune Drug Candidate KG006 to Taisho Pharmaceutical for Japan
Partnership Aims to Expand Autoimmune Treatment Development in Japan Kaigene, Inc., a biotechnolo...
Read storyPage 1 of 2
